Abstract:

The development of functioning endometrial tissue in the abdominal wall after a cesarean birth is an uncommon case phenomenon known as scar endometriosis. Aside from the pelvis, endometriosis most often manifests in the bladder, gastrointestinal system, and, most notably, after obstetric surgical procedures. Here we present a case of caesarean scar endometriosis in a pregnant woman of 30 years of age. The patient has a history of type 1 diabetes mellitus, is now taking insulin and oral hypoglycaemic medications, and is being treated for hypothyroidism. She said that the region around her prior cesarean scar was swollen and painful periodically. USG showed ill defined heterogeneous hypo-echoic subcutaneous mass lesion approximately measuring 3*2*3cms over the right lateral one third of the caesarean scar site.MRI report showing a well-defined hypointense lesion in the anterior abdominal wall in the previous caesarean scar site suggestive of scar endometriosis. A total of three masses were removed, and scar endometriosis was verified by histology.

References:

[1].   Choudhury, H., Pandey, M., Hua, C. K., Mun, C. S., Jing, J. K., Kong, L., Ern, L. Y., Ashraf, N. A., Kit, S. W., Yee, T. S., Pichika, M. R., Gorain, B., & Kesharwani, P., 2018, An Update on Natural Compounds in the Remedy of Diabetes Mellitus: A Systematic Review. Journal of Traditional and Complementary Medicine, 8(3): 361–376. https://doi.org/10.1016/J.Jtcme.2017.08.012(2018)

[2].   Kharroubi, A. T., 2015, Diabetes Mellitus: The Epidemic of the Century. World Journal of Diabetes, 6(6): 850. https://doi.org/10.4239/Wjd.V6.I6.850

[3].   International Diabetes Federation, 2021, IDF Diabetes Atlas, 10th Edition. https://idf.org/About-Diabetes/Diabetes-Facts-Figures/(2021)

[4].   Missoun, F., 2018, Antidiabetic Bioactive Compounds from Plants. Medical Technologies Journal, 2(2): 199–214. https://doi.org/10.26415/2572-004x-Vol2iss2p199-214(2018)

[5].   Caro-Ordieres, T., Marín-Royo, G., Opazo-Ríos, L., Jiménez-Castilla, L., Moreno, J. A., Gómez-Guerrero, C., & Egido, J., 2020, The Coming Age of Flavonoids in the Treatment of Diabetic Complications. Journal of Clinical Medicine, 9(2): 346. https://doi.org/10.3390/Jcm9020346(2020)

[6].   AL-Ishaq, Abotaleb, Kubatka, Kajo, & Büsselberg, 2019, Flavonoids and their Anti-Diabetic Effects: Cellular Mechanisms and Effects to Improve Blood Sugar Levels. Biomolecules, 9(9): 430. https://doi.org/10.3390/Biom9090430(2019)

[7].   Venugopala, K. N., Chaudhary, J., Sharma, V., Jain, A., Kumar, M., Sharma, D., & Et Al., 2022, Exploring the Potential of Flavonoids as Efflorescing Antidiabetic: An Updated SAR and Mechanistic Based Approach. Pharmacognosy Magazine, 18(80): 791-807. https://www.Phcog.Com/Text.Asp?2022/18/80/791/357236(2022)

[8].   Bai, L., Li, X., He, L., Zheng, Y., Lu, H., Li, J., Zhong, L., Tong, R., Jiang, Z., Shi, J., & Li, J., 2019, Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review. The American Journal of Chinese Medicine, 47(05): 933–957. https://doi.org/10.1142/S0192415x19500496(2019)

[9].   Sohretoglu, D., & Sari, S., 2019, Flavonoids as Alpha-Glucosidase Inhibitors: Mechanistic Approaches Merged with Enzyme Kinetics and Molecular Modelling. Phytochemistry Reviews, 19(5): 1081–1092. https://doi.org/10.1007/S11101-019-09610-6(2019)

[10].  Ke, R. Q., Wang, Y., Hong, S. H., & Xiao, L. X., 2023, Anti-Diabetic Effect of Quercetin in Type 2 Diabetes Mellitus by Regulating the MicroRNA-92b-3p/EGR1 Axis. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society, 74(2). https://doi.org/10.26402/Jpp.2023.2.03(2023)

[11].  Ansari, P., Choudhury, S. T., Seidel, V., Rahman, A. B., Aziz, Md. A., Richi, A. E., Rahman, A., Jafrin, U. H., Hannan, J. M. A., & Abdel-Wahab, Y. H. A., 2022, Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus. Life, 12(8): 1146. https://doi.org/10.3390/Life12081146(2022)

[12].  Yang, Y., Chen, Z., Zhao, X., Xie, H., Du, L., Gao, H., & Xie, C., 2022, Mechanisms of Kaempferol in the Treatment of Diabetes: A Comprehensive and Latest Review. Frontiers in Endocrinology, 13. https://doi.org/10.3389/Fendo.2022.990299(2022)

[13].  Kumari, G., Nigam, V. K., & Pandey, D. M., 2022, The Molecular Docking and Molecular Dynamics Study of Flavonol Synthase and Flavonoid 3’-Monooxygenase Enzymes Involved for the Enrichment of Kaempferol. Journal of Biomolecular Structure and Dynamics, 41(6): 2478–2491. https://doi.org/10.1080/07391102.2022.2033324(2022)

[14].  Qaddoori, M. H., & Al-Shmgani, H. S., 2023, Galangin-Loaded Gold Nanoparticles: Molecular Mechanisms of Antiangiogenesis Properties in Breast Cancer. International Journal of Breast Cancer, 2023: 1–14. https://doi.org/10.1155/2023/3251211(2023)

[15].  Al Duhaidahawi, D., Hasan, S. A., & Al Zubaidy, H. F. S., 2021, Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels. Current Diabetes Reviews, 17(6). https://doi.org/10.2174/1573399817666201207200346(2021)

[16].  Mathew, M. G., Jeevanandan, G., Vishwanathaiah, S., Hamzi, K. A., Depsh, M. A. N., & Maganur, P. C., 2022, Parental and Child Outlook on the Impact of ECC on Oral Health-Related Quality of Life: A Prospective Interventional Study. The Journal of Contemporary Dental Practice, 23(9), 877–882. https://doi.org/10.5005/Jp-Journals-10024-3397(2022)

[17].  Jayaraman, S., Natarajan, S. R., Veeraraghavan, V. P., 2023, Unveiling the Anti-Cancer Mechanisms of Calotropin: Insights into Cell Growth Inhibition, Cell Cycle Arrest, and Metabolic Regulation in Human Oral Squamous Carcinoma Cells (HSC-3). Journal of Oral Biology and Craniofacial Research, 13(6), 704–713. https://doi.org/10.1016/J.Jobcr.2023.09.002(2023)

[18].  Liao, Y., Hu, X., Pan, J., & Zhang, G., 2022, Inhibitory Mechanism of Baicalein on Acetylcholinesterase: Inhibitory Interaction, Conformational Change, and Computational Simulation. Foods, 11(2): 168. https://doi.org/10.3390/Foods11020168(2022)

[19].  Chan, S.-H., Hung, C.-H., Shih, J.-Y., Chu, P.-M., Cheng, Y.-H., Tsai, Y.-J., Lin, H.-C., & Tsai, K.-L., 2016, Baicalein is an Available Anti-Atherosclerotic Compound Through Modulation of Nitric Oxide-Related Mechanism Under OxLDL Exposure. Oncotarget, 7(28): 42881–42891. https://doi.org/10.18632/Oncotarget.10263 (2016)

[20]. Cazarolli, L., Zanatta, L., Alberton, E., Bonorino Figueiredo, M. S., Folador, P., Damazio, R., Pizzolatti, M., & Barreto Silva, F. R., 2008, Flavonoids: Prospective Drug Candidates. Mini-Reviews in Medicinal Chemistry, 8(13): 1429–1440. https://doi.org/10.2174/138955708786369564(2008)